Melanocortin-1 receptor-mediated signalling pathways activated by NDP-MSH and HBD3 ligands

Pigment Cell and Melanoma Research

Volumn 25, Issue 3, 2012, Pages 370-374

  Beaumont, Kimberley A ^a,c   Smit, Darren J ^a   Liu, Yan Yan ^a   Chai, Eric ^a   Patel, Mira P ^b   Millhauser, Glenn L ^b   Smith, Jennifer J ^a   Alewood, Paul F ^a   Sturm, Richard A ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CENTENARY INSTITUTE   (Australia)

Author keywords

cAMP; HBD3; MAPK; MC1R; NDP MSH; Pigmentation

Indexed keywords

BETA DEFENSIN 3; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; MELANOCORTIN 1 RECEPTOR; MELANOCORTIN RECEPTOR AGONIST; MITOGEN ACTIVATED PROTEIN KINASE; AGOUTI PROTEIN; ALPHA INTERMEDIN; ANTINEOPLASTIC AGENT; BETA DEFENSIN; BETA DEFENSIN 3, HUMAN; BETA-DEFENSIN 3, HUMAN; DRUG DERIVATIVE; LIGAND; MSH, 4 NLE 7 PHE ALPHA; MSH, 4-NLE-7-PHE-ALPHA-;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL SURFACE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME KINETICS; HAIR COLOR; HUMAN; HUMAN CELL; IN VITRO STUDY; MELANOCYTE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SKIN COLOR; CELL STRAIN HEK293; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; DRUG SCREENING; METABOLISM; PHYSIOLOGY; UPREGULATION;

AGOUTI; CANIS FAMILIARIS;

AGOUTI SIGNALING PROTEIN; ALPHA-MSH; ANTICARCINOGENIC AGENTS; BETA-DEFENSINS; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; HEK293 CELLS; HUMANS; LIGANDS; MAP KINASE SIGNALING SYSTEM; MELANOCYTES; RECEPTOR, MELANOCORTIN, TYPE 1; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84865330408     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/j.1755-148X.2012.00990.x     Document Type: Article

References (17)

1. Anderson, T.M., Vonholdt, B.M., Candille, S.I. et al. (2009). Molecular and evolutionary history of melanism in North American gray wolves. Science 323, 1339-1343.
2. Beaumont, K.A., Newton, R.A., Smit, D.J., Leonard, J.H., Stow, J.L., and Sturm, R.A. (2005). Altered cell surface expression of human MC1R variant receptor alleles associated with red hair and skin cancer risk. Hum. Mol. Genet. 14, 2145-2154.
3. Beaumont, K.A., Shekar, S.L., Newton, R.A., James, M.R., Stow, J.L., Duffy, D.L., and Sturm, R.A. (2007). Receptor function, dominant negative activity and phenotype correlations for MC1R variant alleles. Hum. Mol. Genet. 16, 2249-2260.
4. Beaumont, K.A., Liu, Y.Y., and Sturm, R.A. (2009). Chapter 4 The Melanocortin-1 Receptor Gene Polymorphism and Association with Human Skin Cancer. Prog. Mol. Biol. Trans. Sci. 88C, 85-153.
5. Beaumont, K.A., Wong, S.S., Ainger, S.A., Liu, Y.Y., Patel, M.P., Millhauser, G.L., Smith, J.J., Alewood, P.F., Leonard, J.H., and Sturm, R.A. (2011). Melanocortin MC(1) receptor in human genetics and model systems. Eur. J. Pharmacol. 660, 103-110.
6. Busca, R., Abbe, P., Mantoux, F., Aberdam, E., Peyssonnaux, C., Eychene, A., Ortonne, J.P., and Ballotti, R. (2000). Ras mediates the cAMP-dependent activation of extracellular signal-regulated kinases (ERKs) in melanocytes. EMBO J. 19, 2900-2910.
7. Candille, S.I., Kaelin, C.B., Cattanach, B.M., Yu, B., Thompson, D.A., Nix, M.A., Kerns, J.A., Schmutz, S.M., Millhauser, G.L., and Barsh, G.S. (2007). A -defensin mutation causes black coat color in domestic dogs. Science 318, 1418-1423.
8. Chen, H., Xu, Z., Peng, L., Fang, X., Yin, X., Xu, N., and Cen, P. (2006). Recent advances in the research and development of human defensins. Peptides 27, 931-940.
9. Clement, K., Dubern, B., Mencarelli, M., Czernichow, P., Ito, S., Wakamatsu, K., Barsh, G.S., Vaisse, C., and Leger, J. (2008). Unexpected endocrine features and normal pigmentation in a young adult patient carrying a novel homozygous mutation in the POMC gene. J. Clin. Endocrinol. Metab. 93, 4955-4962.
10. Glaser, R., Navid, F., Schuller, W., Jantschitsch, C., Harder, J., Schroder, J.M., Schwarz, A., and Schwarz, T. (2009). UV-B radiation induces the expression of antimicrobial peptides in human keratinocytes in vitro and in vivo. J. Allergy Clin. Immunol. 123, 1117-1123.
11. Harder, J., Bartels, J., Christophers, E., and Schroder, J.M. (2001). Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem. 276, 5707-5713.
12. Herraiz, C., Jimenez-Cervantes, C., Zanna, P., and Garcia-Borron, J.C. (2009). Melanocortin 1 receptor mutations impact differentially on signalling to the cAMP and the ERK mitogen-activated protein kinase pathways. FEBS Lett. 583, 3269-3274.
13. Herraiz, C., Journe, F., Abdel-Malek, Z., Ghanem, G., Jimenez-Cervantes, C., and Garcia-Borron, J.C. (2011). Signaling from the human melanocortin 1 receptor to ERK1 and ERK2 mitogen-activated protein kinases involves transactivation of cKIT. Mol. Endocrinol. 25, 138-156.
14. Hida, T., Wakamatsu, K., Sviderskaya, E.V. et al. (2009). Agouti protein, mahogunin, and attractin in pheomelanogenesis and melanoblast-like alteration of melanocytes: a cAMP-independent pathway. Pigment Cell Melanoma Res. 22, 623-634.
15. McNulty, J.C., Jackson, P.J., Thompson, D.A., Chai, B., Gantz, I., Barsh, G.S., Dawson, P.E., and Millhauser, G.L. (2005). Structures of the agouti signaling protein. J. Mol. Biol. 346, 1059-1070.
16. Newton, R.A., Roberts, D.W., Leonard, J.H., and Sturm, R.A. (2007). Human melanocytes expressing MC1R variant alleles show impaired activation of multiple signaling pathways. Peptides 28, 2387-2396.
17. Smith, A.G., Luk, N., Newton, R.A., Roberts, D.W., Sturm, R.A., and Muscat, G.E. (2008). Melanocortin-1 receptor signaling markedly induces the expression of the NR4A nuclear receptor subgroup in melanocytic cells. J. Biol. Chem. 283, 12564-12570.